Enanta Pharmaceuticals
ENTA
#8450
Rank
A$0.26 B
Marketcap
$12.54
Share price
-4.18%
Change (1 day)
-36.70%
Change (1 year)

Operating Margin for Enanta Pharmaceuticals (ENTA)

Operating Margin as of February 2025 (TTM): -145.67%

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -145.67%. At the end of 2023 the company had an Operating Margin of -165.39%.

Operating Margin history for Enanta Pharmaceuticals from 2012 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-165.39%16.62%
2022-141.82%27.97%
2021-110.82%287.58%
2020-28.59%-228.79%
201922.20%-50.74%
201845.07%71.95%
201726.21%-28.95%
201636.89%-52.7%
201577.98%93.21%
201440.36%34.38%
201330.03%-41.46%
201251.31%-7.81%
201155.66%63.54%
201034.03%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
12.95%-108.89%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-112.14%๐Ÿ‡บ๐Ÿ‡ธ USA
44.37%-130.46%๐Ÿ‡บ๐Ÿ‡ธ USA
3.14%-102.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-17.34%-88.10%๐Ÿ‡บ๐Ÿ‡ธ USA
26.37%-118.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.